30 kilometers between the Sullivan mine and the Sully

New Post Public Reply Private Reply Replies (0) Message Board
Ulf53
144
30 kilometers between the Sullivan mine and the Sully project. This is the former producing Sullivan zinc mine;

SULLIVAN ZINC MINE – KOOTENAY BC, CANADA
In operation for about 100 years, the Sullivan Mine of Teck Resources was one of the world’s largest SEDEX silver, lead, zinc deposits. Over its life Sullivan produced 17 million tonnes of lead and zinc and 337 million ounces of silver from 150 million tonnes of feed. At current prices value of production was US $49 Billion.


Notice the large numbers of lead and silver as well - important facts.
A silver rally can be in the making... if similar results can be achieved (or even half of it ) at the Sully, this will be a huge upside to the zinc part.


The questions; we know they did testing of the property before they claimed it - must have been at least "fairly good" - otherwise this strong crew would not have continued and bought the rights to it.


Despite having made a relative clear computer image of the deposit (with different tests and various equipment), they have not made the one drilling whole, that is strong enough without doubts. Why ?


They are talking about complicated terrain/rock and a bit unluck.
Yes, it can be so. I understand one seldom get it right the first time - (when you find a confirmed deposit) yet; they have to "make it" this season. Results that is strong enough to continue, so they can narrow it down better.


The plus; these guys are the top of the line, really. They have put a significant part of there own funds, when they started the project.
With all this knowledge and experience (see the website), it`s almost impossible they want have a viable deposit.


Pre-testing and long time professional team; this have been examined in so many angels as can be - and the computer image confirms a deposit - now they "only" have to get the numbers of zinc etc higher.


Read More: https://investorshangout.com/post/view?id=491...z54lRQN7fx
Robert
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Understanding Rollins' Current Market Position and Outlook

Updated Category News Views 226

Analyzing Rollins Inc.'s Stock Performance As we look at the current performance of Rollins Inc. (NYSE: ROL), the shares are trading around $55.73, reflecting a decrease of 1.24% in the recent session. While the stock has dipped by 3.81% over the past month, it has impressively increased by 10.91% year-over-year. This presents a curious juxtaposition of short-term...

Continue Reading
Silver One Reports Major Mineral Resource Estimate for Candelaria

Updated Category News Views 199

Candelaria Project Mineral Resource Estimate Silver One Resources Inc. (OTCQX: SLVRF) has made a significant announcement regarding the completion of a mineral resource estimate for the Candelaria Project. This estimate is prepared in accordance with the National Instrument 43-101, ensuring that the resources are assessed with high standards of transparency and accuracy....

Continue Reading
Investors Alert: Zynex (ZYXI) Faces Serious Legal Scrutiny

Updated Category News Views 197

Legal Investigation into Zynex, Inc. The Law Offices of Frank R. Cruz have announced a crucial investigation regarding Zynex, Inc. (ZYXI) focused on potential violations of federal securities laws. This investigation comes as a response to significant concerns raised about the company's recent financial disclosures and their implications for investors. Understanding the...

Continue Reading
Understanding Rentokil Initial's Stock Valuation Insights

Updated Category News Views 100

Assessing Rentokil Initial's Stock Performance In the current trading session, Rentokil Initial Inc. (NYSE: RTO) shares are priced at $26.42, witnessing a notable increase of 1.46%. Over the past month, the stock has gained 1.40%, though it has faced a decline of 7.78% in the last year. This fluctuation raises questions among shareholders regarding its valuation, despite...

Continue Reading
Innovative Insights on Efzofitimod from aTyr Pharma's Recent Conference

Updated Category News Views 177

aTyr Pharma Highlights Efzofitimod at Key Conference At a significant scientific gathering, aTyr Pharma, Inc. (Nasdaq: ATYR), a clinical stage biotechnology firm known for its innovative therapeutic approaches, shared compelling data concerning efzofitimod. This presentation underlined important insights about the treatment of pulmonary sarcoidosis. The conference, which...

Continue Reading